These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36962380)

  • 1. Technical efficiency of national HIV/AIDS spending in 78 countries between 2010 and 2018: A data envelopment analysis.
    Allel K; Abou Jaoude GJ; Birungi C; Palmer T; Skordis J; Haghparast-Bidgoli H
    PLOS Glob Public Health; 2022; 2(8):e0000463. PubMed ID: 36962380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource needs and gap analysis in achieving universal access to HIV/AIDS services: a data envelopment analysis of 45 countries.
    Zeng W; Shepard DS; Avila-Figueroa C; Ahn H
    Health Policy Plan; 2016 Jun; 31(5):624-33. PubMed ID: 26552409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010-19: a data envelopment and stochastic frontier analysis.
    Abou Jaoude GJ; Garcia Baena I; Nguhiu P; Siroka A; Palmer T; Goscé L; Allel K; Sinanovic E; Skordis J; Haghparast-Bidgoli H
    Lancet Glob Health; 2022 May; 10(5):e649-e660. PubMed ID: 35427522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.
    Haakenstad A; Moses MW; Tao T; Tsakalos G; Zlavog B; Kates J; Wexler A; Murray CJL; Dieleman JL
    Lancet HIV; 2019 Jun; 6(6):e382-e395. PubMed ID: 31036482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern, Determinants, and Impact of HIV Spending on Care and Treatment in 38 High-Burden Low- and Middle-Income Countries.
    Granich R; Gupta S; Montaner J; Williams B; Zuniga JM
    J Int Assoc Provid AIDS Care; 2016; 15(2):91-100. PubMed ID: 26715490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review.
    Granich R; Gupta S; Hall I; Aberle-Grasse J; Hader S; Mermin J
    PLoS Med; 2017 Apr; 14(4):e1002253. PubMed ID: 28376085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden and changes in HIV/AIDS morbidity and mortality in Southern Africa Development Community Countries, 1990-2017.
    Gona PN; Gona CM; Ballout S; Rao SR; Kimokoti R; Mapoma CC; Mokdad AH
    BMC Public Health; 2020 Jun; 20(1):867. PubMed ID: 32503604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2020 5-11 Sep; 396(10252):693-724. PubMed ID: 32334655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financing the response to HIV in low-income and middle-income countries.
    Izazola-Licea JA; Wiegelmann J; Arán C; Guthrie T; De Lay P; Avila-Figueroa C
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S119-26. PubMed ID: 19901624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the efficiency of countries in making progress towards universal health coverage: a data envelopment analysis of 172 countries.
    Jordi E; Pley C; Jowett M; Abou Jaoude GJ; Haghparast-Bidgoli H
    BMJ Glob Health; 2020 Oct; 5(10):. PubMed ID: 33115858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of investments in monitoring the HIV epidemic: how far have we come? A descriptive analysis.
    Alfven T; McDougal L; Frescura L; Aran C; Amler P; Gill W
    Health Res Policy Syst; 2014 Oct; 12():62. PubMed ID: 25322764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
    Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
    J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa.
    Granich R; Gupta S; Williams B
    Int J STD AIDS; 2022 Jan; 33(1):4-17. PubMed ID: 34565233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
    Staveteig S; Croft TN; Kampa KT; Head SK
    PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries.
    Zeng W; Shepard DS; Chilingerian J; Avila-Figueroa C
    BMC Health Serv Res; 2012 Mar; 12():74. PubMed ID: 22443135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries.
    Amico P; Gobet B; Avila-Figueroa C; Aran C; De Lay P
    BMC Public Health; 2012 Mar; 12():221. PubMed ID: 22436141
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.